Today: 9 April 2026
GEV stock price holds $717 after outlook lift, but wind delays keep traders cautious
30 January 2026
2 mins read

GEV stock price holds $717 after outlook lift, but wind delays keep traders cautious

New York, January 29, 2026, 19:24 (EST) — After-hours

Shares of GE Vernova Inc (GEV.N) ticked up 0.8%, closing at $717.39 on Thursday. After-hours trading saw little movement. The stock swung between $681.70 and $722.57 during the session.

The stock gained further ground following the earnings release, with the energy equipment maker projecting 2026 revenue between $44 billion and $45 billion—well above Wall Street’s $41.97 billion consensus from LSEG. The company cited robust demand for gas turbines and power gear, driven by rising electricity consumption tied to data centers and artificial intelligence. Reuters

Why it matters now: Orders for GE Vernova’s Power and Electrification units are piling up faster than shipments can keep pace. Investors are zeroing in on the backlog — work sold but undelivered — as a key near-term measure. CEO Scott Strazik said the company is “entering 2026 with significant momentum,” despite ongoing efforts to steady its Wind segment. GE Vernova

The fourth quarter delivered a solid but somewhat uneven picture on headline profit. Orders hit $22.2 billion, with revenue at $11.0 billion. Adjusted EBITDA—a key profit measure excluding interest, taxes, and certain items—came in at $1.2 billion, according to the earnings release. Free cash flow, the cash left after capital expenditures, totaled $1.8 billion. Net income was boosted by a $2.9 billion tax benefit from a U.S. valuation allowance release. GE Vernova

Management highlighted the ramp-up in grid and data-center capacity on the call. Strazik noted that Electrification orders for data centers topped “over $2 billion” for 2025. Meanwhile, Power’s equipment backlog and “slot reservation agreements” climbed to 83 gigawatts — these commitments effectively lock in turbine production slots. The Motley Fool

The updated targets hinge on a deal acting as a near-term catalyst. GE Vernova lifted its 2026 free cash flow forecast to a range of $5.0 billion to $5.5 billion, maintaining an adjusted EBITDA margin between 11% and 13% in its multi-year outlook. An earnings presentation noted this assumes the February 2 closing of its $5.275 billion acquisition of the remaining 50% stake in transformer-maker Prolec GE. GE Vernova

Cash returns are backing the stock ahead of Friday’s session. The company disclosed in an SEC filing that it bought back roughly 1.9 million shares for $1.1 billion during the quarter. It also boosted its share repurchase authorization from $6 billion to $10 billion. On top of that, it declared a quarterly dividend of 50 cents per share, payable February 2, doubling the previous 25 cents. SEC

Wind continues to be the key variable — the detail traders can’t stop revisiting. CFO Ken Parks reported contract losses climbed following a halt in installations at Vineyard Wind off Massachusetts. He cautioned the project risks missing the end of March deadline if work doesn’t pick up quickly, as the company stands to lose use of a specialized vessel. Renewables Now

The company flagged a tariff drag and expects Wind to remain unprofitable this year, projecting around $400 million in segment EBITDA losses by 2026. Vineyard Wind alone could slash wind revenue by about $250 million if it fails to bill for unfinished turbines. Investing.com

The downside remains clear: if offshore turbine issues persist or major projects face more delays, cash could stay locked in unfinished gear, squeezing margins despite ongoing order growth in Power and Electrification. The tax benefit that lifted Q4 net income complicates efforts to gauge “real” run-rate earnings for investors. GE Vernova

The upcoming key date is February 2, marking the anticipated close of the Prolec GE deal and the payment of the increased dividend. After that, the company’s first-quarter 2026 earnings webcast is set for April 22. GE Vernova

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Uber stock snaps a five-day slide as Waabi robotaxi pact draws focus ahead of earnings
Previous Story

Uber stock snaps a five-day slide as Waabi robotaxi pact draws focus ahead of earnings

Chevron stock rises as Venezuela export plans and Tengiz restart come into focus ahead of earnings
Next Story

Chevron stock rises as Venezuela export plans and Tengiz restart come into focus ahead of earnings

Go toTop